Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT SCIENCES CORP Director's Dealing 2018

Mar 14, 2018

30597_dirs_2018-03-13_df6c3a65-9cb8-4d63-b104-e79056156b76.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2018-03-09

Reporting Person: LIDGARD GRAHAM PETER (Chief Science Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-03-09 Common Stock M 6125 $23.38 Acquired 200074 Direct
2018-03-09 Common Stock S 6125 $50.939 Disposed 193949 Direct
2018-03-09 Common Stock M 8425 $0.00 Acquired 202374 Direct
2018-03-12 Common Stock S 3961 $52.194 Disposed 198413 Direct
2018-03-13 Common Stock S 4464 $53.21 Disposed 193949 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-03-09 Stock Option (right to buy) $23.38 M 6125 Disposed 2025-03-09 Common Stock (6125) Direct
2018-03-09 Restricted Stock Units $ M 8425 Disposed Common Stock (8425) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 12340 Indirect

Footnotes

F1: Represents shares of common stock received upon exercise of a stock option award.

F2: The sales reported in this field were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2017.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.85 to $50.96, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

F4: Represents shares of common stock received upon vesting of a restricted stock unit award.

F5: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on March 9, 2018.

F6: This option vests and becomes exercisable in four equal annual installments beginning on March 9, 2016.

F7: Each restricted stock unit represents a contingent right to receive one share of common stock.

F8: Represents a restricted stock unit award granted on March 9, 2015 that partially vested on March 9, 2018. The restricted stock units vest in four equal annual installments beginning on March 9, 2016.